NCT01229943
Clinical Trial Information
Trial Number: NCT01229943 (ClinicalTrials.gov)
Disease Type:
- Endocrine Neoplasm - Neuroendocrine Cancer
Trial Title:
"Randomized Phase II Study of Everolimus Alone Versus Everolimus Plus Bevacizumab in Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors"
Study ID:
CALGB-80701
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®